Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1699965

registered interest
date	12/04/2024
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Teachers: Veterans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, pursuant to the Answer of 15 March 2024 to Question 17304 on Teachers: Veterans, how many people applied for the undergraduate veteran teaching bursary in the academic years (a) 2022-23 and (b) 2023-24; and what steps he is taking to increase the number of undergraduate veteran teachers.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	20858
answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>Initial teacher training (ITT) providers are responsible for the management and administration of bursary payments, including assessment of eligibility. Trainees do not need to apply for a bursary and will automatically receive this from their ITT provider if eligible.</p><p>The undergraduate veteran teaching bursary is paid over the final two years of the course, with £20,000 payable in each year. In the 2022/23 and 2023/24 academic years, five individual trainees received the undergraduate veteran teaching bursary, three of whom received a bursary in both years. Figures may be subject to change due to ongoing data collection and assurance.</p><p>The department supports veterans into teaching in primary, secondary, and further education through its broad support services and bursaries. Since the publication of its commitments in the ‘Veterans Strategy Action Plan 2022 to 2024’, the department has tailored support and communications for the veteran community including dedicated teacher training advisers, webpages, case study blogs on the ‘Get Into Teaching’ website and information in Civvy Street publications. More information from Get Into Teaching is available here: <a href="https://getintoteaching.education.gov.uk/funding-and-support/if-youre-a-veteran" target="_blank">https://getintoteaching.education.gov.uk/funding-and-support/if-youre-a-veteran</a> and here: <a href="https://getintoteaching.education.gov.uk/blog/from-the-army-to-teacher-training" target="_blank">https://getintoteaching.education.gov.uk/blog/from-the-army-to-teacher-training</a>. More information from Civvy Street can be found here: <a href="https://civvystreetmagazine.co.uk/2023/05/bring-your-unique-perspective-to-the-classroom-get-into-teaching-2/" target="_blank">https://civvystreetmagazine.co.uk/2023/05/bring-your-unique-perspective-to-the-classroom-get-into-teaching-2/</a>.</p><p>Also available are bespoke webinars, and the opportunity to attend regional employer fairs with the Career Transition Partnership (CTP) and British Forces Resettlement Service (BFRS). More information about the CTP can be found here: <a href="https://www.ctp.org.uk/job-finding/directory/get-into-teaching" target="_blank">https://www.ctp.org.uk/job-finding/directory/get-into-teaching</a>. More information about the BFRS can be found here: <a href="https://www.bfrss.org.uk/profiles/companies/986419/" target="_blank">https://www.bfrss.org.uk/profiles/companies/986419/</a>.</p><p> </p> answering member constituency East Hampshire answering member printed Damian Hinds question first answered 17/04/2024 12:07:05 answering member 3969 label Biography information for Damian Hinds
tabling member	298 label Biography information for Steve McCabe

1699966

registered interest
date	12/04/2024
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	International Seabed Authority
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister of State, Foreign, Commonwealth and Development Office, whether he plans to support a third term for the Secretary-General of the International Seabed Authority.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	20929
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>FCDO Ministers will consider the UK position in advance of the upcoming election for the Secretary-General of the International Seabed Authority. The question of mineral-resources related activities in the seabed beyond the limits of national jurisdiction for the benefit of humankind is a critical one, and the outcome of this election will have wide significance.</p> answering member constituency Sutton Coldfield answering member printed Mr Andrew Mitchell question first answered 24/04/2024 09:23:57 answering member 1211 label Biography information for Mr Andrew Mitchell
tabling member	1491 label Biography information for Kerry McCarthy

1699967

registered interest
date	12/04/2024
answering body	Department for Energy Security and Net Zero
answering dept id	215
answering dept short name	Energy Security and Net Zero
answering dept sort name	Energy Security and Net Zero
hansard heading	Electricity: Trade Competitiveness
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Energy Security and Net Zero, whether her Department has made an assessment of the potential impact of recoupling the GB and EU day-ahead electricity markets without recoupling the intraday markets on the competitiveness of wholesale electricity markets.
tabling member constituency	Southampton, Test
tabling member printed	Dr Alan Whitehead
uin	20832
answer	answer is ministerial correction date of answer 18/04/2024 answer text <p>In 2021, HMG consulted on current arrangements for trading electricity on power exchanges in the GB wholesale electricity market and outlined proposals to support efficient cross-border trading. That consultation focused on day-ahead trading but also sought views on the intraday timeframe.</p><p> </p><p>HMG’s consultation response outlined the intention to legislate to achieve a single GB clearing price in the day-ahead timeframe, subject to engagement with the UK-EU Specialised Committee on Energy, industry and stakeholders to ensure HMG is well placed to make a final decision on progressing legislation. HMG confirmed development of efficient arrangements in other timeframes should remain under review.</p><p> </p><p><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fconsultations%2Fre-coupling-great-britain-electricity-auctions-for-cross-border-trade&amp;data=05%7C02%7CParliamentary.PQ%40energysecurity.gov.uk%7C9dbf59c61a9840a5fc6108dc5eb48023%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C638489376545896472%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=1jIrxOoYdZ9KDXIcs7XbqjXkva8LU8q8cAtzpOs3nyM%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/consultations/re-coupling-great-britain-electricity-auctions-for-cross-border-trade</a></p> answering member constituency West Aberdeenshire and Kincardine answering member printed Andrew Bowie question first answered 18/04/2024 05:58:51 answering member 4601 label Biography information for Andrew Bowie
tabling member	62 label Biography information for Dr Alan Whitehead

1699968

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of medication costs on community pharmacies.
tabling member constituency	Gosport
tabling member printed	Dame Caroline Dinenage
uin	20988
answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>Through the medicine margin survey, the Department assesses whether the reimbursement arrangements pay pharmacy contractors as agreed as part of the community pharmacy contractual framework (CPCF). The medicine margin survey considers what pharmacies paid for medicines by looking at their invoices compared to the amount reimbursed by the National Health Service. Where the survey finds that they have been underpaid, we increase the pharmacy contractors’ payments, and where they have been overpaid, we decrease payments.</p><p>Furthermore, where pharmacies cannot purchase products at or below the Drug Tariff NHS reimbursement price, Community Pharmacy England can request that the Department reassesses the reimbursement price. If a new reimbursement price is issued, this is known as a concessionary price.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20979 question first answered 19/04/2024 09:54:36 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4008 label Biography information for Dame Caroline Dinenage

1699969

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she plans to increase core community pharmacy funding.
tabling member constituency	Gosport
tabling member printed	Dame Caroline Dinenage
uin	20989
answer	answer is ministerial correction date of answer 18/04/2024 answer text <p>As part of the Community Pharmacy Contractual Framework five-year deal, we committed £2.6 billion every year to community pharmacy, and agreed not to recover £212 million in over delivered fees and margin from community pharmacies in recent years. In addition, we are now investing up to £645 million across 2023/24 and 2024/25 in Pharmacy First, for more blood pressure checks and more contraception consultations in pharmacy. We have begun the consultation with Community Pharmacy England on the national funding and contractual framework arrangements for 2024/25.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 18/04/2024 16:00:23 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4008 label Biography information for Dame Caroline Dinenage

1699970

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she plans to increase the scope of the Pharmacy First programme.
tabling member constituency	Gosport
tabling member printed	Dame Caroline Dinenage
uin	20990
answer	answer is ministerial correction date of answer 18/04/2024 answer text <p>Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service, and keep the conditions covered by Pharmacy First under review.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 18/04/2024 16:57:21 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4008 label Biography information for Dame Caroline Dinenage

1699971

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she plans to develop a Priority Review programme for medical devices.
tabling member constituency	Gosport
tabling member printed	Dame Caroline Dinenage
uin	20991
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Priority Review programme is not currently planned, but the Government is taking other significant steps for medical device regulatory reform, as part of a broader Medical Technology Strategy. Further information on the Medical Technology Strategy is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy" target="_blank">https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy</a></p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating medical devices, and designates United Kingdom Approved Bodies to conduct conformity assessments against the relevant regulatory requirements. The MHRA works closely with Approved Bodies to ensure their timely assessment.</p><p> </p><p>Following a consultation on the future regulation of medical devices in 2021, the MHRA is leading a programme of work to introduce updated regulations for medical devices that prioritise patient safety, improve patient access to innovative medical devices, and ensure the UK remains an attractive market for medical technology innovators. In January of this year, the MHRA published a MedTech Regulatory roadmap that sets out the main activities in implementing the future regulations throughout 2024 and 2025. An international recognition framework for medical devices will form part of the future regulatory framework, which will provide an alternative route to the UK’s market, by leveraging approvals from comparable international regulators. The MHRA aims to publish an outline of the International Recognition Framework for medical devices later this spring, aligned to the Life Sciences Council, subject to necessary approvals.</p><p>In addition, the MHRA is leading the reform of the medical devices regulatory landscape and includes a new pathway to accelerate access to safe, innovative medical devices to help meet the unmet needs of patients. The Innovative Devices Access Pathway aims to bring new medical technologies and solutions to the National Health Service, to support the medical needs that are not currently being met. There are eight innovative medical technologies included in the pilot phase.</p><p>We are working alongside others to further the Life Sciences Vision, particularly improving regulation and regulatory processes around medical devices, and supporting broader ambitions in the vision aligned to the conditions set out in the Major Conditions Strategy. As we work to update the medical devices regulatory landscape, the MHRA is taking the Major Conditions Strategy into consideration, including the six groups of major health conditions.</p><p>The National Institute for Health and Care Excellence (NICE) is not a regulator but makes recommendations for the NHS on whether selected medical devices should be routinely adopted by the NHS, based on an assessment of their costs and benefits. Medical devices are prioritised for the NICE’s evaluation, in line with NICE’s published topic selection manual.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20992 20993 question first answered 22/04/2024 11:22:39 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4008 label Biography information for Dame Caroline Dinenage

1699972

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Reviews
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 23 June 2023 to Question 189729 on Medicines and Healthcare products Regulatory Agency, whether she plans to initiate a priority review for medical devices.
tabling member constituency	Gosport
tabling member printed	Dame Caroline Dinenage
uin	20992
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Priority Review programme is not currently planned, but the Government is taking other significant steps for medical device regulatory reform, as part of a broader Medical Technology Strategy. Further information on the Medical Technology Strategy is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy" target="_blank">https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy</a></p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating medical devices, and designates United Kingdom Approved Bodies to conduct conformity assessments against the relevant regulatory requirements. The MHRA works closely with Approved Bodies to ensure their timely assessment.</p><p> </p><p>Following a consultation on the future regulation of medical devices in 2021, the MHRA is leading a programme of work to introduce updated regulations for medical devices that prioritise patient safety, improve patient access to innovative medical devices, and ensure the UK remains an attractive market for medical technology innovators. In January of this year, the MHRA published a MedTech Regulatory roadmap that sets out the main activities in implementing the future regulations throughout 2024 and 2025. An international recognition framework for medical devices will form part of the future regulatory framework, which will provide an alternative route to the UK’s market, by leveraging approvals from comparable international regulators. The MHRA aims to publish an outline of the International Recognition Framework for medical devices later this spring, aligned to the Life Sciences Council, subject to necessary approvals.</p><p>In addition, the MHRA is leading the reform of the medical devices regulatory landscape and includes a new pathway to accelerate access to safe, innovative medical devices to help meet the unmet needs of patients. The Innovative Devices Access Pathway aims to bring new medical technologies and solutions to the National Health Service, to support the medical needs that are not currently being met. There are eight innovative medical technologies included in the pilot phase.</p><p>We are working alongside others to further the Life Sciences Vision, particularly improving regulation and regulatory processes around medical devices, and supporting broader ambitions in the vision aligned to the conditions set out in the Major Conditions Strategy. As we work to update the medical devices regulatory landscape, the MHRA is taking the Major Conditions Strategy into consideration, including the six groups of major health conditions.</p><p>The National Institute for Health and Care Excellence (NICE) is not a regulator but makes recommendations for the NHS on whether selected medical devices should be routinely adopted by the NHS, based on an assessment of their costs and benefits. Medical devices are prioritised for the NICE’s evaluation, in line with NICE’s published topic selection manual.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20991 20993 question first answered 22/04/2024 11:22:39 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4008 label Biography information for Dame Caroline Dinenage

1699973

registered interest
date	12/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) the Medicines and Healthcare products Regulatory Agency and (b) NICE will prioritise the regulatory timelines for medical devices that (i) respond to conditions outlined in the Major Conditions Strategy and (ii) where there is unmet need.
tabling member constituency	Gosport
tabling member printed	Dame Caroline Dinenage
uin	20993
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Priority Review programme is not currently planned, but the Government is taking other significant steps for medical device regulatory reform, as part of a broader Medical Technology Strategy. Further information on the Medical Technology Strategy is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy" target="_blank">https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy</a></p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating medical devices, and designates United Kingdom Approved Bodies to conduct conformity assessments against the relevant regulatory requirements. The MHRA works closely with Approved Bodies to ensure their timely assessment.</p><p> </p><p>Following a consultation on the future regulation of medical devices in 2021, the MHRA is leading a programme of work to introduce updated regulations for medical devices that prioritise patient safety, improve patient access to innovative medical devices, and ensure the UK remains an attractive market for medical technology innovators. In January of this year, the MHRA published a MedTech Regulatory roadmap that sets out the main activities in implementing the future regulations throughout 2024 and 2025. An international recognition framework for medical devices will form part of the future regulatory framework, which will provide an alternative route to the UK’s market, by leveraging approvals from comparable international regulators. The MHRA aims to publish an outline of the International Recognition Framework for medical devices later this spring, aligned to the Life Sciences Council, subject to necessary approvals.</p><p>In addition, the MHRA is leading the reform of the medical devices regulatory landscape and includes a new pathway to accelerate access to safe, innovative medical devices to help meet the unmet needs of patients. The Innovative Devices Access Pathway aims to bring new medical technologies and solutions to the National Health Service, to support the medical needs that are not currently being met. There are eight innovative medical technologies included in the pilot phase.</p><p>We are working alongside others to further the Life Sciences Vision, particularly improving regulation and regulatory processes around medical devices, and supporting broader ambitions in the vision aligned to the conditions set out in the Major Conditions Strategy. As we work to update the medical devices regulatory landscape, the MHRA is taking the Major Conditions Strategy into consideration, including the six groups of major health conditions.</p><p>The National Institute for Health and Care Excellence (NICE) is not a regulator but makes recommendations for the NHS on whether selected medical devices should be routinely adopted by the NHS, based on an assessment of their costs and benefits. Medical devices are prioritised for the NICE’s evaluation, in line with NICE’s published topic selection manual.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20991 20992 question first answered 22/04/2024 11:22:40 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4008 label Biography information for Dame Caroline Dinenage

1699974

registered interest
date	12/04/2024
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Import Controls: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to the Answer of 12 March 2024 to Question 13303, whether he plans to lay the statutory instruments required to enable the border target operating model under the affirmative or negative parliamentary procedure.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	21011
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>The following SIs required by the Border Target Operating Model have now been laid, and are listed along with the parliamentary procedure by which they were laid:</p><p> </p><p>PH/050: Negative</p><p>PH/055: Negative</p><p>OFC/016: Affirmative</p><p>PH/040: Affirmative</p> answering member constituency Sherwood answering member printed Sir Mark Spencer question first answered 24/05/2024 08:30:16 answering member 4055 label Biography information for Sir Mark Spencer
tabling member	4088 label Biography information for Stella Creasy